REYOMI
Superior Relief 17: Advanced G-Protein Research Samples
High-purity SUPERIOR for analytical and in-vitro research.
The Evolution of Harm Reduction Research
The landscape of opioid use has shifted dramatically in recent years, moving away from traditional botanical or pharmaceutical sources toward high-potency synthetic agonists. Locally, the emergence of compounds such as nitazenes (zenes) and cychlorphine has created an unprecedented challenge for researchers and harm reduction advocates. These substances are characterized by extreme potency—often many times that of fentanyl—and a rapid, aggressive escalation of physiological tolerance. As these high-potency synthetics become more prevalent, traditional transition methods often prove insufficient or result in severe precipitated withdrawal. This has created an urgent, local need for rigorous research into alternative pathways, specifically focusing on biased signaling and tolerance reversal.
Addressing the Crisis Through Science
Our mission is to provide the high-purity reference materials necessary to study these mechanisms. By exploring how SR-17018 interacts with receptors saturated by high-potency synthetics, independent researchers are finding new data on how to safely navigate the “off-ramps” of modern opioid dependency.
We believe that providing access to these compounds for analytical and observational research is a critical step in addressing the current crisis and uncovering the next generation of harm reduction protocols.
Why Biased Signaling Matters
Traditional mu-opioid receptor (MOR) agonists activate two primary pathways: the G-protein pathway (which provides relief) and the beta-arrestin pathway (which is associated with side effects like respiratory depression and the development of tolerance).
SR-17018 is a G-protein biased agonist. This means it is designed to activate the beneficial G-protein signaling while avoiding the beta-arrestin recruitment that drives the “vicious cycle” of addiction. Research suggests this mechanism may allow for:
Tolerance Reversal: Effectively “resetting” the subject’s sensitivity to opioids, a phenomenon observed in both animal studies and independent investigative reports.
Withdrawal Attenuation: Managing the acute physical symptoms of cessation without the risk of respiratory failure.
Reyomi
The journey starts here!!
500mg
$45
Powder for easy concentrations.
Discreet packaging for all shipments.
Satisfaction guaranteed with a robust return policy and responsive customer support.
Secure checkout with encrypted payment processing and trusted partners. Fast, reliable delivery to your door.
1000mg
$80
Free shipping on orders over $50
All packages are prepared in a research-grade carrier
Satisfaction guaranteed with a robust return policy and responsive customer support.
Secure checkout with encrypted payment processing and trusted partners.
Fast, reliable delivery to your door.
